Asia Pacific Medical Exoskeleton Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Medical Exoskeleton Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Medical Exoskeleton Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Medical Exoskeleton Market Regional Analysis

6.2 Asia Pacific Medical Exoskeleton Market Revenue 2020-2031 (US$ Million)

6.3 Asia Pacific Medical Exoskeleton Market Forecast Analysis

7. Asia Pacific Medical Exoskeleton Market Analysis – by Component

7.1 Hardware

7.1.1 Overview
7.1.2 Hardware: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

7.2 Software

7.2.1 Overview
7.2.2 Software: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

8. Asia Pacific Medical Exoskeleton Market Analysis – by Type

8.1 Powered Exoskeleton

8.1.1 Overview
8.1.2 Powered Exoskeleton: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

8.2 Passive Exoskeleton

8.2.1 Overview
8.2.2 Passive Exoskeleton: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

9. Asia Pacific Medical Exoskeleton Market Analysis – by Extremity

9.1 Lower Body Exoskeleton

9.1.1 Overview
9.1.2 Lower Body Exoskeleton: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

9.2 Upper Body Exoskeleton

9.2.1 Overview
9.2.2 Upper Body Exoskeleton: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

9.3 Full Body Exoskeleton

9.3.1 Overview
9.3.2 Full Body Exoskeleton: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

10. Asia Pacific Medical Exoskeleton Market Analysis – by Application

10.1 Spinal Cord Injury

10.1.1 Overview
10.1.2 Spinal Cord Injury: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

10.2 Multiple Sclerosis

10.2.1 Overview
10.2.2 Multiple Sclerosis: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

10.3 Stroke

10.3.1 Overview
10.3.2 Stroke: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

10.4 Cerebral Palsy

10.4.1 Overview
10.4.2 Cerebral Palsy: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

10.5 Parkinson\'s Disease

10.5.1 Overview
10.5.2 Parkinson\'s Disease: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

11. Asia Pacific Medical Exoskeleton Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific

11.2.1 Asia Pacific Medical Exoskeleton Market Breakdown, by Key Country, 2023 and 2031 (%)
11.2.1.1 Asia Pacific Medical Exoskeleton Market – Revenue and Forecast Analysis – by Country
11.2.1.1 China: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 China: Asia Pacific Medical Exoskeleton Market Breakdown, by Component
11.2.1.1.2 China: Asia Pacific Medical Exoskeleton Market Breakdown, by Type
11.2.1.1.3 China: Asia Pacific Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.1.4 China: Asia Pacific Medical Exoskeleton Market Breakdown, by Application

11.2.1.2 India: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 India: Asia Pacific Medical Exoskeleton Market Breakdown, by Component
11.2.1.2.2 India: Asia Pacific Medical Exoskeleton Market Breakdown, by Type
11.2.1.2.3 India: Asia Pacific Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.2.4 India: Asia Pacific Medical Exoskeleton Market Breakdown, by Application

11.2.1.3 Japan: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 Japan: Asia Pacific Medical Exoskeleton Market Breakdown, by Component
11.2.1.3.2 Japan: Asia Pacific Medical Exoskeleton Market Breakdown, by Type
11.2.1.3.3 Japan: Asia Pacific Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.3.4 Japan: Asia Pacific Medical Exoskeleton Market Breakdown, by Application

11.2.1.4 Australia: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 Australia: Asia Pacific Medical Exoskeleton Market Breakdown, by Component
11.2.1.4.2 Australia: Asia Pacific Medical Exoskeleton Market Breakdown, by Type
11.2.1.4.3 Australia: Asia Pacific Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.4.4 Australia: Asia Pacific Medical Exoskeleton Market Breakdown, by Application

11.2.1.5 Rest of Asia-Pacific: Asia Pacific Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Rest of Asia-Pacific: Asia Pacific Medical Exoskeleton Market Breakdown, by Component
11.2.1.5.2 Rest of Asia-Pacific: Asia Pacific Medical Exoskeleton Market Breakdown, by Type
11.2.1.5.3 Rest of Asia-Pacific: Asia Pacific Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.5.4 Rest of Asia-Pacific: Asia Pacific Medical Exoskeleton Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Ekso Bionics Holdings Inc\r\n

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Lifeward, Inc\r\n

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 ExoAtlet\r\n

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Cyberdyne Inc\r\n

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 BIONIK\r\n

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 B-Temia Inc\r\n

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Hocoma AG\r\n

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Myomo Inc\r\n

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Rex Bionics Ltd.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia Pacific Medical Exoskeleton Market